Page 2 - Rick Strassman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rick strassman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rick Strassman Today - Breaking & Trending Today

Ayahuasca and DMT: A Portal into the Universal Mind

Explore the historical tapestry of Ayahuasca and DMT across civilizations and their transformative power. Discover Ayahuasca retreats for spiritual exploration and personal growth. ....

Rick Strassman , Terence Mckenna , Indigenous Wisdom , South Pacific , Psychedelic Renaissance , Retreats Have Opened , Tradition Meets Modern , Spiritual Potential ,

Speaking to people who found God after taking psychedelics

Speaking to people who found God after taking psychedelics
dazeddigital.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dazeddigital.com Daily Mail and Mail on Sunday newspapers.

Los Angeles , United States , Rick Strassman , Roland Griffiths , Textbrit Dawsonillustrationcallum Abbott , Museum Of Natural History In Los Angeles , John Hopkins University , Roman Catholic , Spirit Molecule , Natural History , Burning Bush , Acacia Bush ,

Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. AGN Neuro is the world’s first company to investigate DMT for the tre ....

British Columbia , United Kingdom , City Of , Christopherj Moreau , Edmundj Safra , David Nutt , Rick Strassman , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Constraint Induced Movement Therapy , Centre For Human Drug Research , Imperial College London , Company Phase , Algernon Neuroscience , Spirit Molecule , Psychedelic Handbook , Human Drug Research , Brain Derived Neurotrophic Factor , Constraint Induced Movement , Clinical Trial Design , Psychedelic Effects , Gn Neuro , Algernon Pharmaceuticals Inc , Pre Clinical Studies , Algernon Neuroscience , Phase 2 Study ,

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Rick Strassman, MD, a clinical researcher, author, and expert in psychedelic medicines, sat down to discuss pharmacists' role in adverse event management. ....

Rick Strassman ,